Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus
Junsheng Fu, Zhaohui Xiong, Caizhi Huang, et al.
Journal of Biological Chemistry (2018) Vol. 294, Iss. 1, pp. 327-340
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

NRF2, a Transcription Factor for Stress Response and Beyond
Feng He, Xiaoli Ru, Tao Wen
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4777-4777
Open Access | Times Cited: 1162
S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate
Wei Qin, Ke Qin, Zhang Yan-ling, et al.
Nature Chemical Biology (2019) Vol. 15, Iss. 10, pp. 983-991
Closed Access | Times Cited: 241
NRF2 as a regulator of cell metabolism and inflammation in cancer
Feng He, Laura Antonucci, Michael Karin
Carcinogenesis (2020) Vol. 41, Iss. 4, pp. 405-416
Open Access | Times Cited: 240
Beyond repression of Nrf2: An update on Keap1
Aleksandra Kopacz, Damian Klóska, Henry Jay Forman, et al.
Free Radical Biology and Medicine (2020) Vol. 157, pp. 63-74
Open Access | Times Cited: 202
Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function
Henry Kurniawan, Davide G. Franchina, Luana Guerra, et al.
Cell Metabolism (2020) Vol. 31, Iss. 5, pp. 920-936.e7
Open Access | Times Cited: 161
Nrf2 as a regulator of mitochondrial function: Energy metabolism and beyond
Noemí Esteras, Andrey Y. Abramov
Free Radical Biology and Medicine (2022) Vol. 189, pp. 136-153
Open Access | Times Cited: 94
Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?
Ruolei Wang, Lirong Liang, Misaki Matsumoto, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 353-353
Open Access | Times Cited: 57
Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease
Shruti Rajan, Kamatham Pushpa Tryphena, Sabiya Samim Khan, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101915-101915
Closed Access | Times Cited: 42
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang, Xiaohua Song, Dingxin Long
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 579-615
Open Access | Times Cited: 27
Thirty years of NRF2: advances and therapeutic challenges
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Potential Applications of NRF2 Modulators in Cancer Therapy
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 130
Nrf2: The Master and Captain of Beta Cell Fate
Sharon Baumel-Alterzon, Liora S. Katz, Gabriel Brill, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 32, Iss. 1, pp. 7-19
Open Access | Times Cited: 79
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
Ya-Chu Tang, Jenn-Ren Hsiao, Shih-Sheng Jiang, et al.
Theranostics (2021) Vol. 11, Iss. 11, pp. 5232-5247
Open Access | Times Cited: 78
NRF2 and Diabetes: The Good, the Bad, and the Complex
Matthew Dodson, Aryatara Shakya, Annadurai Anandhan, et al.
Diabetes (2022) Vol. 71, Iss. 12, pp. 2463-2476
Open Access | Times Cited: 48
Normal and Pathological NRF2 Signalling in the Central Nervous System
Tony Heurtaux, David Bouvier, Alexandre Bénani, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1426-1426
Open Access | Times Cited: 45
Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks
Ke Xu, Jie Ma, Sean R. R. Hall, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 704-723
Open Access | Times Cited: 37
Electrophilic metabolites targeting the KEAP1/NRF2 partnership
Albena T. Dinkova‐Kostova, Henriikka Hakomäki, Anna‐Liisa Levonen
Current Opinion in Chemical Biology (2024) Vol. 78, pp. 102425-102425
Open Access | Times Cited: 13
A comprehensive review on signaling attributes of serine and serine metabolism in health and disease
Di Wu, Kejia Zhang, Faheem Ahmed Khan, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129607-129607
Closed Access | Times Cited: 11
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
Emiliano Panieri, Pelin Telkoparan‐Akillilar, Síbel Süzen, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 791-791
Open Access | Times Cited: 69
Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
Janine M. DeBlasi, Gina M. DeNicola
Cancers (2020) Vol. 12, Iss. 10, pp. 3023-3023
Open Access | Times Cited: 66
Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease
Navneet Ammal Kaidery, Manuj Ahuja, Bobby Thomas
Molecular and Cellular Neuroscience (2019) Vol. 101, pp. 103413-103413
Open Access | Times Cited: 62
Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression
Yadav Sangeeta Muthyalaiah, Bhavana Jonnalagadda, Cordelia Mano John, et al.
Glycoconjugate Journal (2021) Vol. 38, Iss. 6, pp. 717-734
Closed Access | Times Cited: 51
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 36
Research on esophageal cancer: With personal perspectives from studies in China and Kenya
Chung S. Yang, Xiaoxin Chen
International Journal of Cancer (2020) Vol. 149, Iss. 2, pp. 264-276
Open Access | Times Cited: 40
Nrf2 Regulates β-Cell Mass by Suppressing β-Cell Death and Promoting β-Cell Proliferation
Sharon Baumel-Alterzon, Liora S. Katz, Gabriel Brill, et al.
Diabetes (2022) Vol. 71, Iss. 5, pp. 989-1011
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top